Publication | Closed Access

Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer

Liver Kinase B1Blockade TherapyMedicineProgrammed Death 1ImmunologyCell DeathImmune Checkpoint InhibitorCancer BiologyTumor SuppressorCancer TreatmentLung CancerOncologyCell BiologyTumor MicroenvironmentTumor Biology